Cargando…

Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts

Detalles Bibliográficos
Autores principales: Pahalyants, Vartan, Murphy, William S., Klebanov, Nikolai, Lu, Chenyue, Theodosakis, Nicholas, Klevens, R. Monina, Estir, Hossein, Lilly, Evelyn, Asgari, Maryam, Semenov, Yevgeniy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428982/
https://www.ncbi.nlm.nih.gov/pubmed/34509536
http://dx.doi.org/10.1016/j.jaad.2021.08.065
_version_ 1783750476806750208
author Pahalyants, Vartan
Murphy, William S.
Klebanov, Nikolai
Lu, Chenyue
Theodosakis, Nicholas
Klevens, R. Monina
Estir, Hossein
Lilly, Evelyn
Asgari, Maryam
Semenov, Yevgeniy R.
author_facet Pahalyants, Vartan
Murphy, William S.
Klebanov, Nikolai
Lu, Chenyue
Theodosakis, Nicholas
Klevens, R. Monina
Estir, Hossein
Lilly, Evelyn
Asgari, Maryam
Semenov, Yevgeniy R.
author_sort Pahalyants, Vartan
collection PubMed
description
format Online
Article
Text
id pubmed-8428982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-84289822021-09-10 Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Lu, Chenyue Theodosakis, Nicholas Klevens, R. Monina Estir, Hossein Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2022-01 2021-09-10 /pmc/articles/PMC8428982/ /pubmed/34509536 http://dx.doi.org/10.1016/j.jaad.2021.08.065 Text en © 2021 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Pahalyants, Vartan
Murphy, William S.
Klebanov, Nikolai
Lu, Chenyue
Theodosakis, Nicholas
Klevens, R. Monina
Estir, Hossein
Lilly, Evelyn
Asgari, Maryam
Semenov, Yevgeniy R.
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
title Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
title_full Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
title_fullStr Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
title_full_unstemmed Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
title_short Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts
title_sort immunosuppressive biologics did not increase the risk of covid-19 or subsequent mortality: a retrospective matched cohort study from massachusetts
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428982/
https://www.ncbi.nlm.nih.gov/pubmed/34509536
http://dx.doi.org/10.1016/j.jaad.2021.08.065
work_keys_str_mv AT pahalyantsvartan immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT murphywilliams immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT klebanovnikolai immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT luchenyue immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT theodosakisnicholas immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT klevensrmonina immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT estirhossein immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT lillyevelyn immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT asgarimaryam immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts
AT semenovyevgeniyr immunosuppressivebiologicsdidnotincreasetheriskofcovid19orsubsequentmortalityaretrospectivematchedcohortstudyfrommassachusetts